ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 3, 2008
Eur Respir J 2008, doi:10.1183/09031936.00159507
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
32/6/1504    most recent
09031936.00159507v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papakonstantinou, E.
Right arrow Articles by Eickelberg, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papakonstantinou, E.
Right arrow Articles by Eickelberg, O.


ORIGINAL ARTICLE

Increased hyaluronic acid content in idiopathic pulmonary arterial hypertension

E. Papakonstantinou 1, F.M. Kouri 2, G. Karakiulakis 1, I. Klangas 1, O. Eickelberg 2*

1 Dept of Pharmacology, Aristotle University School of Medicine, Thessaloniki, Greece
2 Dept of Medicine, University of Giessen Lung Center, Justus Liebig University, Giessen, Germany

* To whom correspondence should be addressed. E-mail: oliver.eickelberg{at}innere.med.uni-giessen.de.


   Abstract

Idiopathic pulmonary arterial hypertension (IPAH) is a fatal disease characterized by elevated blood pressure in the pulmonary circulation. Initial vasoconstriction, proliferation of pulmonary arterial smooth muscle cells (PASMC), and increased deposition of extracellular matrix (ECM) contribute to pathologic remodelling of pulmonary arterioles in IPAH. Glycosaminoglycans (GAG), components of the ECM, control cellular proliferation and differentiation, but their expression in IPAH remains elusive.

Here, we investigated GAG expression in lungs of patients with IPAH or control transplant donors, and analyzed expression and localization of GAG metabolizing enzymes in vivo and in vitro. We detected a significant increase in the expression of hyaluronic acid (HA) in IPAH lungs, associated with increased hyaluronan synthase (HAS) 1 and decreased hyaluronoglucosaminidase (HYAL) 1 gene expression, assessed by quantitative (q)RT-PCR and Western blotting. HAS1 protein localized to PASMC in vivo, and increased HA deposition was observed in remodelled pulmonary arteries in IPAH. TGF-{beta}1, a profibrotic growth factor, led to increased HA secretion and HAS1 expression in primary PASMC.

Our results demonstrate an increased HA content in IPAH lungs, associated with increased HAS1 and decreased HYAL1 gene expression. Synergistic regulation of GAG metabolizing enzymes in favour of accumulation may thus regulate pathologic vascular remodelling in IPAH lungs.

Keywords:  Hyaluronic acid, pulmonary arterial hypertension, pulmonary arterial smooth muscle cells, TGF-{beta}1, vascular remodelling




This article has been cited by other articles:


Home page
Eur Respir JHome page
I. Klagas, S. Goulet, G. Karakiulakis, J. Zhong, M. Baraket, J. L. Black, E. Papakonstantinou, and M. Roth
Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD
Eur. Respir. J., September 1, 2009; 34(3): 616 - 628.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Hamid and J. H. Newman
Evidence for Inflammatory Signaling in Idiopathic Pulmonary Artery Hypertension: TRPC6 and Nuclear Factor-{kappa}B
Circulation, May 5, 2009; 119(17): 2297 - 2298.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.